Increasing the Potential Interacting Area of Nanomedicine Enhances Its Homotypic Cancer Targeting Efficacy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32049490.
- Also identified by DOI 10.1021/acsnano.9b08798.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The cancer cell membrane contains an arsenal of highly specific homotypic moieties that can be used to recognize its own kind. These cell membranes are often used to coat spherical nanoparticles to enhance nanomedicines' targeting specificities and uptakes. A sphere, however, has only a point contact with a surface at any given time. It is shown here that, by retaining a flatter morphology of the cracked cell membrane through stiffening with <i>in situ</i> synthesized gold nanomaterials, an increased area of interaction could be maintained and hence improve upon the <i>in vitro</i> and <i>in vivo</i> homotypic targeting capabilities between cancer cell types. This enhancement is especially important <i>in vivo</i> as any nanomedicine with targeting moieties probably has a single pass at interacting with the target cell before subsequent system clearance. Possible future clinical applications may involve the usage of a patient's autologous tumor biopsy tissues, which are very limited in supply, and therefore ensuring that we capitalize on the entire collective surface area of the cancer cell membrane available becomes an important consideration in the design and delivery our cell membrane-derived nanomedicines.
Medical subject headings
- Antibiotics, Antineoplastic
- Doxorubicin
- Melanoma
- Nanomedicine